Published in Am J Pathol on January 01, 1985
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84
Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation (1985) 1.75
Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol (1986) 1.73
Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol (1986) 1.63
Angiography of liver transplantation patients. Radiology (1985) 1.53
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc (1987) 1.35
A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology (1989) 1.30
Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology (1986) 1.27
Hepatic artery thrombosis after liver transplantation: radiologic evaluation. AJR Am J Roentgenol (1986) 1.26
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
Biopsy findings in cases of rejection of liver allograft. J Clin Pathol (1985) 1.24
Transplantation for primary biliary cirrhosis. Gastroenterology (1988) 1.12
OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc (1991) 1.08
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol (1995) 1.08
Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn (2000) 1.06
Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol (1993) 1.03
Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc (1987) 1.00
Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms. Transplant Proc (1989) 0.90
Isolation and primary cultures of human intrahepatic bile ductular epithelium. In Vitro Cell Dev Biol (1988) 0.90
Neuropathologic findings after liver transplantation. Acta Neuropathol (1992) 0.90
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg (1988) 0.83
Liver transplant rejection: angiographic findings in 35 patients. AJR Am J Roentgenol (1987) 0.83
The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc (1995) 0.82
Massive haemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol (1989) 0.81
Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc (1992) 0.81
Beta-2-microglobulin expression in the liver after liver transplantation. J Clin Pathol (1988) 0.79
Cytokeratin immunostaining for detection of biliary epithelium: its use in counting bile ducts in cases of liver allograft rejection. J Clin Pathol (1994) 0.79
Primary cultures of human intrahepatic (biliary) epithelial cells. Transplant Proc (1988) 0.78
Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010. Int J Med Sci (2013) 0.78
Opportunities and costs of clinical research. Semin Liver Dis (1985) 0.75
[Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center]. Helv Chir Acta (1989) 0.75
Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. Transplant Proc (1988) 0.75
Causes of death after liver transplantation in children treated with cyclosporine and steroids. Clin Transplant (1989) 0.75
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
Evolution of liver transplantation. Hepatology (1982) 19.54
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease. Nature (1981) 2.71
Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65
Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Bacteria and disease of the biliary tract. Gut (1971) 1.41
Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol (1972) 1.40
Liver transplantation: the pathologist's perspective. Pathol Annu (1979) 1.38
Pathology of liver transplantation. Transplant Rev (1969) 1.36
Expression of HLA-DR antigens on bileduct cells of rejected liver transplant. Lancet (1984) 1.31
Pathology of liver transplantation. Transplantation (1976) 1.21
Ductular damage in liver transplant rejection: its similarity to that of primary biliary cirrhosis and graft-versus-host disease. Pathol Annu (1981) 1.20
HEPATIC ALTERATIONS IN OBSTRUCTIVE JAUNDICE. Am J Clin Pathol (1964) 1.19
Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection. J Infect Dis (1982) 1.11
Expression of the major histocompatibility complex antigens on different liver cellular components in rat and man. Scand J Immunol (1981) 1.11
Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis. A review of morphology and clinical, biochemical, and immunologic features. Hum Pathol (1972) 1.06
Hepatitis in an adult caused by Herpes simplex virus type I. Gastroenterology (1976) 1.05
Histopathology of serial graft biopsies from liver transplant recipients. Am J Pathol (1984) 1.03
Fulminant herpes simplex hepatitis in an adult: report of a case in renal transplant recipient. Gastroenterology (1976) 0.99
Primary biliary cirrhosis: diagnosis, pathology and pathogenesis. Postgrad Med J (1983) 0.97
Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms. Hum Pathol (1984) 0.97
Infarction of the human liver. J Clin Pathol (1963) 0.96
Post-transfusion chronic liver disease. Gastroenterology (1976) 0.96
Abnormal bile duct epithelium in chronic aggressive hepatitis and primary biliary cirrhosis. Hum Pathol (1972) 0.95
Fatalities following exposure to 2-nitropropane. J Occup Med (1978) 0.95
Postnatal cytomegalovirus hepatitis. An autopsy and liver biopsy study. Hum Pathol (1974) 0.94
Extrahepatic cholestasis. III. Chronology of histologic changes in the liver. Am J Clin Pathol (1959) 0.92
The graft-versus-host reaction. Hum Pathol (1983) 0.89
Hepatic infarction. Hum Pathol (1972) 0.87
Evolution of liver transplantation. Hepatology (1982) 19.54
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Liver transplantation (1). N Engl J Med (1989) 4.53
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Three-dimensional photoacoustic imaging of blood vessels in tissue. Opt Lett (1998) 3.12
Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01